University of California San Francisco
Give to UCSF
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
A new UCSF study in mice has pinpointed a specific pattern of brain waves that underlies the ability to let go of old, irrelevant learned associations to make way for new updates.
UCSF researchers have become to the first to solve the structure of a hard-working protein that helps reload neurons for repeated firing.
Ketogenic diets have a dramatic impact on the microbes residing in the human gut, collectively referred to as the microbiome, according to a new UCSF study.
A new study from UCSF Benioff Children’s Hospitals suggests that for some hospitals, video visits may become a permanent feature of the patient-provider landscape.
Smoking significantly worsens COVID-19, according to a new analysis by UCSF of the association between smoking and progression of the infectious disease.
UCSF researchers have identified a powerful self-corrective mechanism within synapses that is activated by neurodegeneration and acts to slow down disease progression in animal models of ALS.
New research confirmed the higher rates of early life respiratory infections among Puerto Ricans.
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
A community-led project to provide comprehensive COVID-19 testing to residents, essential workers, and first responders in the town of Bolinas has determined that all of the 1,845 nasal and oral swab tests conducted in the community between April 20 and April 24 were negative for active infection with the novel coronavirus SARS-CoV-2, which causes COVID-19.
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.
Lung damage is the cause of most COVID-19 deaths, and lung damage also is a public health concern for smokers and anybody living under polluted skies.
